What Is the IQSU ETF? Returns, Expense Ratio, Holdings and Alternative ETFs
The New York Life Candriam U.S. Large Cap ETF (IQSU) is a passive product that selects U.S. large-cap stocks using ESG criteria and quantitative metrics. Its quantitative ESG screening structure and its differences in selection and weighting versus SPY, VOO and QUAL are the key factors in choosing it.
SubscribeWhat Is the New York Life Candriam U.S. Large Cap ETF?
It is a passive ETF that quantitatively selects U.S. large-cap stocks based on environmental, social and governance criteria. It maintains exposure close to the broad market while adjusting stock weights using ESG ratings and quantitative metrics.
It suits investors who want to add an ESG perspective and quantitative screening to their U.S. large-cap investments.
It is an ETF managed by New York Life using a passive (index-tracking) approach.
How Does the New York Life Candriam U.S. Large Cap ETF Invest?
| Item | Details |
|---|---|
| Investment target | U.S. large-cap stocks |
| Management style | Passive (ESG and quantitative screening) |
| Selection criteria | Environmental, social and governance factors + quantitative metrics |
| Dividend frequency | Quarterly |
| Total expense ratio | 0.09% |
The ETF tracks an index that combines environmental, social and governance ratings with quantitative metrics to adjust the weights of U.S. large-cap stocks. While maintaining exposure close to the broad market, it reduces companies that fall short of ESG criteria and adds weight to highly rated stocks, reflecting both a responsible investing perspective and quantitative screening.
- Selection combining ESG criteria and quantitative metrics
- Weight adjustments while maintaining market exposure
New York Life Candriam U.S. Large Cap ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $342.8M, and the total expense ratio is 0.09% per year.
Compared with simple market-cap-weighted large-cap ETFs, the main points of comparison are ESG and quantitative screening and weight adjustments.
New York Life Candriam U.S. Large Cap ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeU.S. large-cap stocks respond to interest rates, earnings seasons and market risk appetite. Because the ESG and quantitative screening strategy maintains exposure close to the broad market, it generally follows market movements, with differences emerging in proportion to its weight adjustments. As a rules-based portfolio, its performance can diverge from a market-cap index.
Fund flows into ESG and quantitative large-cap products vary with market risk appetite and demand for sustainability, and when interest in responsible investing rises, money sometimes shifts toward this product category. It is also worth watching how performance changes with interest rates and the economic cycle.
New York Life Candriam U.S. Large Cap ETF Pros and Cons
Its strengths are ESG and quantitative screening and the maintenance of market exposure, while tracking differences, limited excess returns and market risk are considerations.
💪 Key Strengths
⚠️ Points to Watch
New York Life Candriam U.S. Large Cap ETF Alternative ETFs and Related Products
For exposure to U.S. large-cap stocks without ESG and quantitative screening, direct substitutes include SPY and VOO, and for those focused on the quality factor, products such as QUAL are also worth comparing. What sets this ETF apart is that it selects U.S. large-cap stocks by combining ESG criteria and quantitative metrics, and its stock selection element is stronger than that of a market-cap index.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 FNDX | Schwab Fundamental U.S. Large Company ETF | $32.71 | -0.6% | $28.6B | 0.25% | 1.44% | +23.3% |
 PRF | Invesco RAFI US 1000 ETF | $56.13 | -0.8% | $10.2B | 0.34% | 1.32% | +23.1% |
 FNDA | Schwab Fundamental U.S. Small Company ETF | $35.98 | -1.3% | $9.0B | 0.25% | 1.23% | +17.6% |
 RECS | Columbia Research Enhanced Core ETF | $44.93 | -1.5% | $6.2B | 0.15% | 0.72% | +10.0% |
 JHMM | John Hancock Multifactor Mid Cap ETF | $73.57 | -1.3% | $6.1B | 0.41% | 0.89% | +14.8% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| AAPL | Apple Inc | 0.20% | $344.63 | -1.2% | $5.03T | 39.5 | 0.32% |
| GOOGL | Alphabet Inc | 0.17% | $279.84 | -1.4% | $3.41T | 14.6 | 0.31% |
| AMZN | Amazon.com Inc | 0.11% | $240.35 | -1.4% | $2.59T | 19.4 | - |
| GOOG | Alphabet Inc | 0.06% | $278.22 | -1.4% | $3.41T | 14.5 | 0.31% |
| MSFT | Microsoft Corp | 0.10% | $521.91 | -1.6% | $3.88T | 27.3 | 0.74% |
New York Life Candriam U.S. Large Cap ETF Investor Checkpoints
Here are the points to review before investing in IQSU. ESG and quantitative screening and the maintenance of market exposure are appealing, but tracking differences, limited excess returns and market risk should be checked in advance. It is also a good idea to compare it with simple market-cap index products.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 🌱 ESG and quantitative | Review the combination of ESG ratings and quantitative metrics | Combined screening |
| 🇺🇸 Market exposure | Review the U.S. large-cap composition and diversification | Market exposure |
| 📊 Tracking difference | Review performance versus the market-cap index | Needs checking |
| 💵 Expense ratio | Check the fees of ESG large-cap ETFs | Needs checking |
The tracking difference resulting from ESG and quantitative screening and the overall market trend are the main variables for long-term performance, and because exposure is close to the market, the scale of excess returns may be limited. During periods of broad market weakness, losses can occur along with the market.
It is a suitable candidate for investors who want to add an ESG perspective and quantitative screening to their U.S. large-cap investments. For large-cap exposure without ESG and quantitative screening, products such as SPY and VOO are options, and for those who want ESG and quantitative screening, it is advisable to compare this product alongside them before choosing.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 10, 2026.
Today's 5 AI picks, all free